Regular Article
Pharmacokinetics of [14C]Genistein in the Rat: Gender-Related Differences, Potential Mechanisms of Biological Action, and Implications for Human Health

https://doi.org/10.1006/taap.2000.8902Get rights and content

Abstract

Mass balance, plasma pharmacokinetics, tissue distribution, and metabolism of [14C]genistein were investigated in male and female rats (n = 5) following an oral dose of [14C]genistein (4 mg kg−1) to determine potential sites and mechanisms of biological action. Mean total excretion of radioactivity in urine and feces for both sexes was 66 and 33% of the dose respectively at 166 h after administration. Mean and maximal concentrations of radioactivity in plasma were significantly (p < 0.02) higher in male than female rats, with half-lives of 12.4 and 8.5 h, respectively. The concentration of radioactivity was significantly (p < 0.002) higher in liver from females than males and in reproductive (vagina, uterus, ovary, and prostate) compared with other peripheral organs. Analysis of plasma extracts by radio-HPLC-MS indicated that the predominant metabolites were genistein glucuronides, 4-hydroxyphenyl-2-propionic acid, and trace amounts of parent compound (<5%). Radioactive residues in uterus and prostate were predominantly parent compound and 4-hydroxyphenyl-2-propionic acid, respectively. Significantly (p < 0.05) increased retention of [14C]genistein or metabolites was associated with reproductive organs, such as vagina, uterus, ovary, and prostate, likely to contain relatively high concentrations of estrogen receptors or binding proteins compared with other peripheral tissues. Factors liable to influence bioavailability of biologically active genistein or metabolites, such as dietary intake, warrant further investigation to determine the risks or benefits for different consumer groups of phytoestrogen-containing foods.

References (41)

  • J. Sfakianos et al.

    Intestinal uptake and biliary excretion of the isoflavone genistein in rats

    J. Nutr.

    (1997)
  • X. Xu et al.

    Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women

    J. Nutr.

    (1994)
  • D.D. Baird et al.

    Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women

    J. Clin. Endocrinol. Metab.

    (1995)
  • S. Barnes et al.

    HPLC-mass spectrometry analysis of isoflavones

    Proc. Soc. Exp. Biol. Med.

    (1998)
  • S. Barnes et al.

    Soy isoflavonoids and cancer prevention

    Adv. Exp. Med. Biol.

    (1996)
  • S. Barnes et al.

    Soybeans inhibit mammary tumours in models of breast cancer

    Prog. Clin. Biol. Res.

    (1990)
  • H. Blair et al.

    Various effects of tyrosine kinase inhibitors on avain osteoclastic activity and reduction of bone loss in ovariectomised rats

    J. Cell Biochem.

    (1996)
  • A.W. Brandenberger et al.

    Tissue distribution of estrogen receptors alpha (ER-α) and beta (ER-β) mRNA in the midgestational human fetus

    J. Clin. Endocrinol. Metab.

    (1997)
  • J. Burne

    Battle of Hearts and Hormones: The Financial Times 2

    (1999)
  • J.F. Couse et al.

    Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse

    Endocrinology

    (1997)
  • Cited by (0)

    View full text